SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : Sepracor-Looks very promising
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: M. Ramle who wrote (2111)3/24/1999 9:12:00 PM
From: John Metcalf  Read Replies (1) of 10280
 
Mazen, I suggest looking at a couple more factors -- general market conditions and heavy institutional ownership. The majority of fund managers are underperforming the averages, simply because they have dared to pick stocks in a very narrow market in which declines are leading advances.

If these managers have held SEPR through its big run from $40 to $140 in eight months or so, they see it as a source of balancing losses and raising cash with which to buy later after the correction has run its course. That's the safe course of action with a correction developing, and it's also a self-fulfilling prophecy when 90% of the stock is held by insiders and institutions.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News